CIK 0001875091 · Non-accelerated filer<br>Emerging growth company
NeuroSense Therapeutics Ltd.
Sign in to watch- Ticker
- NRSN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972-9-9531142
- Business address
- 11 HAMENOFIM ST., BUILDING B, HERZLIYA, Israel, 4672562
Securities
- NRSN Ordinary Shares Nasdaq
- NRSNW Warrant Nasdaq
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 424B4 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- FWP Offering Free Writing Prospectus
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- CORRESP Other Correspondence Between Filers and SEC Staff
- F-1/A Offering Registration Statement for Certain Foreign Private Issuers
- 8-A12B Other Registration of Securities
- UPLOAD Other SEC-generated Letter
- FWP Offering Free Writing Prospectus
Page 15 of 16 · 314 filings